Tagged: , ,

Viewing 0 reply threads
  • Author
    Posts
    • #21487
      John Connor
      Keymaster

      NVG-291 may help rebuild myelin in MS patients.

      It’s currently going through the single ascending dose (SAD) part of the testing. As this has been very successful its developers are proposing it now move onto the multiple ascending dose (MAD) stage.

      Apart from the somewhat undermining medical acronyms, this looks like really promising news.

      Hope? What are your thoughts?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account